The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Open accessAbstract
Background—: The French pulmonary hypertension (PH) registry allows the survey of epidemiological trends. Isolated cases of precapillary PH have been reported in patients who have chronic myelogenous leukemia treated with the tyrosine kinase inhibitor dasatinib. Methods and Results—: This study was designed to describe incident cases of dasatinib-associated PH reported in the French PH registry. From the approval of dasatinib (November 2006) to September 30, 2010, 9 incident cases treated by dasatinib at the time of PH diagnosis were identified. At diagnosis, patients had moderate to severe precapillary PH with functional and hemodynamic impairment. No other incident PH cases were exposed to other tyrosine kinase inhibitors at the time of PH diagnosis. Clinical, functional, or hemodynamic improvements were observed within 4 months of dasatinib discontinuation in all but 1 patient. Three patients required PH treatment with endothelin receptor antagonist (n=2) or calcium channel blocker (n=1). After a median follow-up of 9 months (min-max 3–36), the majority of patients did not demonstrate complete clinical and hemodynamic recovery, and no patients reached a normal value of mean pulmonary artery pressure (≤20 mm Hg). Two patients (22%) died at follow-up (1 of unexplained sudden death and 1 of cardiac failure in the context of septicemia, respectively, 8 and 12 months after dasatinib withdrawal). The lowest estimate of incident PH occurring in patients exposed to dasatinib in France was 0.45%. Conclusions—: Dasatinib may induce severe precapillary PH fulfilling the criteria of pulmonary arterial hypertension, thus suggesting a direct and specific effect of dasatinib on pulmonary vessels. Improvement is usually observed after withdrawal of dasatinib.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Self-citationNilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Saglio, G., Kim, D.-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912614 · Cited by 1,678
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Self-citationGuidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Self-citationCardiotoxicity of the cancer therapeutic agent imatinib mesylate
Kerkelä, R., Grazette, L., Yacobi, R., Iliescu, C., Patten, R., Beahm, C., Walters, B., Shevtsov, S., Pesant, S., Clubb, F. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1446 · Cited by 1,159
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Reversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Kovacs, G., Berghold, A., Scheidl, S., & Olschewski, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00145608 · Cited by 1,057
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M., Sitbon, O., Yaïci, A., Montani, D., O'Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 674
Self-citationRix, U., Hantschel, O., Dürnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., et al. (2007) · Blood · doi:10.1182/blood-2007-07-102061 · Cited by 671
Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Montani, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1037oc · Cited by 472
Self-citationQuintás-Cardama, A., Kantarjian, H., O'Brien, S., Borthakur, G., Bruzzi, J., Munden, R., & Cortes, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0329 · Cited by 388
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Ghofrani, H. A., Morrell, N. W., Hoeper, M. M., Olschewski, H., Peacock, A. J., Barst, R. J., Shapiro, S., Golpon, H., Toshner, M., Grimminger, F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0123oc · Cited by 384
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Self-citationGirerd, B., Montani, D., Coulet, F., Sztrymf, B., Yaici, A., Jaïs, X., Tregouet, D., Reis, A., Drouin-Garraud, V., Fraisse, A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200908-1284oc · Cited by 304
Self-citationCheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., Yancopoulos, G. D., Cerretti, D. P., Daniel, T. O., & Chen, J. (2002) · PubMed · Cited by 255
Congestive heart failure is a rare event in patients receiving imatinib therapy
Atallah, E., Durand, J.-B., Kantarjian, H., & Cortes, J. (2007) · Blood · doi:10.1182/blood-2007-01-070144 · Cited by 252
Merklinger, S. L., Jones, P. L., Martinez, E. C., & Rabinovitch, M. (2005) · Circulation · doi:10.1161/circulationaha.105.540542 · Cited by 245
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
Austin, E. D., Cogan, J. D., West, J. D., Hedges, L. K., Hamid, R., Dawson, E. P., Wheeler, L. A., Parl, F. F., Loyd, J. E., & Phillips, J. A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00010409 · Cited by 236
Izikki, M., Guignabert, C., Fadel, E., Humbert, M., Tu, L., Zadigue, P., Dartevelle, P., Simonneau, G., Adnot, S., Maitre, B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35070 · Cited by 217
Self-citationBMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Humbert, M., Deng, Z., Simonneau, G., Barst, R. J., Sitbon, O., Wolf, M., Cuervo, N., Moore, K. J., Hodge, S. E., Knowles, J. A., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01762002 · Cited by 211
Self-citationWill, Y., Dykens, J. A., Nadanaciva, S., Hirakawa, B., Jamieson, J., Marroquin, L. D., Hynes, J., Patyna, S., & Jessen, B. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn157 · Cited by 205
Molecular Cancer BioMed Central Molecular 12002, Cancer
Lynch, C. A., Tycko, B., Bestor, T. H., & Walsh, C. P. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-2 · Cited by 202
Chintalgattu, V., Ai, D., Langley, R. R., Zhang, J., Bankson, J. A., Shih, T. L., Reddy, A. K., Coombes, K. R., Daher, I. N., Pati, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39434 · Cited by 188
Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Series
Bergeron, A., Réa, D., Levy, V., Picard, C., Meignin, V., Tamburini, J., Bruzzoni-Giovanelli, H., Calvo, F., Tazi, A., & Rousselot, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-715cr · Cited by 184
Self-citationTu, L., Dewachter, L., Gore, B., Fadel, É., Dartevelle, P., Simonneau, G., Humbert, M. J. C., Eddahibi, S., & Guignabert, C. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0317oc · Cited by 173
Self-citationLong term imatinib treatment in pulmonary arterial hypertension
Souza, R. (2006) · Thorax · doi:10.1136/thx.2006.064097 · Cited by 165
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Souza, R., Humbert, M. J. C., Sztrymf, B., Jaïs, X., Yaici, A., Pavec, J. L., Parent, F., Hervé, P., Soubrier, F., Sitbon, O., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00104807 · Cited by 163
Self-citationRole of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
Dahal, B. K., Cornitescu, T., Tretyn, A., Pullamsetti, S. S., Kosanovic, D., Dumitrascu, R., Ghofrani, H. A., Weißmann, N., Voswinckel, R., Banat, G.-A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1682oc · Cited by 130
Girerd, B., Montani, D., Eyries, M., Yaïci, A., Sztrymf, B., Coulet, F., Sitbon, O., Simonneau, G., Soubrier, F., & Humbert, M. J. C. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-73 · Cited by 106
Self-citationRasheed, W. K., Flaim, B., & Seymour, J. F. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.026 · Cited by 106
Mediator scandal rocks French medical community
Mullard, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60334-6 · Cited by 93
cSrc is a major cytosolic tyrosine kinase in vascular tissue
Oda, Y., RENAUX, B. S., Bjorge, J. D., Saifeddine, M., Fujita, D. J., & Hollenberg, M. D. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-052 · Cited by 81
Fenfluramine-like cardiovascular side-effects of benfluorex
Boutet, K., Frachon, I., Jobic, Y., Gut‐Gobert, C., Leroyer, C., Carlhant-Kowalski, D., Sitbon, O., Simonneau, G., & Humbert, M. J. C. (2009) · European Respiratory Journal · doi:10.1183/09031936.00086308 · Cited by 79
Self-citationZhao, R. C., Jiang, Y., & Verfaillie, C. M. (2001) · Blood · doi:10.1182/blood.v97.8.2406 · Cited by 75
Guilpain, P., Montani, D., Damaj, G. L., Achouh, L., Lefrère, F., Pavec, J. L., Marfaing‐Koka, A., Dartevelle, P., Simonneau, G., Humbert, M. J. C., et al. (2007) · Respiration · doi:10.1159/000112822 · Cited by 71
Self-citationOrlandi, E. M., Rocca, B., Pazzano, A. S., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.08.007 · Cited by 70
Ramaraj, P., Singh, H., Niu, N., Chu, S., Holtz, M., Yee, J. K., & Bhatia, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3656 · Cited by 68
Hennigs, J. K., Keller, G., Baumann, H. J., Honecker, F. U., Kluge, S., Bokemeyer, C., Brümmendorf, T. H., & Klose, H. F. E. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-30 · Cited by 61
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Adir, Y., & Humbert, M. J. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00175909 · Cited by 54
Self-citationDasatinib-Induced Pleural Effusions: A Lymphatic Network Disorder?
Goldblatt, M. R., Huggins, J. T., Doelken, P., Gurung, P., & Sahn, S. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181ae9227 · Cited by 38
Giles, F. (2009) · Drug Design Development and Therapy · doi:10.2147/dddt.s3069 · Cited by 32
Humbert, M. J. C., Simonneau, G., & Dinh‐Xuan, A. T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00075211 · Cited by 8
Self-citation
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationUpdated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationLyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Self-citation
Metadata
- Authors
- Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., Poubeau, P., Girerd, B., Natali, D., Guignabert, C., Perros, F., O'Callaghan, D. S., Jaïs, X., Tubert-Bitter, P., Zalcman, G., Sitbon, O., Simonneau, G., & Humbert, M.
- Venue
- Circulation
- Published
- 2012-05
- Volume
- 125
- Issue
- 17
- Pages
- 2128-2137
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2070507117
- Cited by
- 659
- References
- 47
- FWCI
- 49.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.